These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2860942)

  • 41. Pharmacological and biochemical actions of sulphasalazine.
    Hoult JR
    Drugs; 1986; 32 Suppl 1():18-26. PubMed ID: 2877850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma.
    Shaw PN; Sivner AL; Aarons L; Houston JB
    J Chromatogr; 1983 May; 274():393-7. PubMed ID: 6135701
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 45. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM; Bartholomew TC; Jewell DP
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
    Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA
    J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK; Piris J; Truelove SC
    Lancet; 1977 Oct; 2(8044):892-5. PubMed ID: 72239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of sulphasalazine.
    Das KM; Dubin R
    Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse effects with oral 5-aminosalicyclic acid.
    Fardy JM; Lloyd DA; Reynolds RP
    J Clin Gastroenterol; 1988 Dec; 10(6):635-7. PubMed ID: 2906645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulphasalazine in ulcerative colitis.
    Michalowski AS
    Gut; 1992 Nov; 33(11):1582. PubMed ID: 1360440
    [No Abstract]   [Full Text] [Related]  

  • 56. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
    Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM
    Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
    Sheldon P; Webb C; Grindulis KA
    Br J Rheumatol; 1988 Oct; 27(5):344-9. PubMed ID: 2902897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
    Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R
    J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.
    Greenfield SM; Punchard NA; Thompson RP
    Gut; 1991 Oct; 32(10):1156-9. PubMed ID: 1683330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.